Literature DB >> 9720045

Temporal changes in the frequency of colicinogeny in Escherichia coli from house mice.

David M Gordon1, Margaret A Riley2, Theodora Pinou2.   

Abstract

Escherichia coli was isolated from feral house mice (Mus domesticus) during the course of a mouse plague in the state of Victoria, Australia. The isolates were characterized for the production of colicins and their resistance to the co-occurring colicins. Of the 447 isolates examined, 59% were found to be colicinogenic. Phenotypic and PCR-based genotypic methods were used to determine the types of colicins being produced. Colicin E2 was the most common, representing 27% of the colicin-producing isolates. Colicin Ia was produced by 3% of the colicinogenic isolates. The remaining colicins could not be identified, but phenotypic and PCR data argue that at least nine different colicin types are present in this collection of E. coli. The frequency of colicinogenic isolates declined from 71% to 43% over the 7 months of the study. All colicin types appeared to decline in frequency. Concurrently, the resistance of isolates to colicin E2 increased from about 50% to 70%. Two hypotheses are proposed to explain the decline in the frequency of colicinogeny in this population of E. coli. The first relates to the within-host interactions occurring among colicinogenic, colicin-susceptible and colicin-resistant populations within a host. The second relates to the among-host interactions between susceptible and colicinogenic populations and the effect of host population densities on these interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720045     DOI: 10.1099/00221287-144-8-2233

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  26 in total

1.  A cka-gfp transcriptional fusion reveals that the colicin K activity gene is induced in only 3 percent of the population.

Authors:  Janez Mulec; Zdravko Podlesek; Peter Mrak; Andreja Kopitar; Alojz Ihan; Darja Zgur-Bertok
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

2.  Tracing contamination and Escherichia coli diversity.

Authors:  Gary A Dykes
Journal:  Appl Environ Microbiol       Date:  2002-09       Impact factor: 4.792

3.  Competitive interactions in Escherichia coli populations: the role of bacteriocins.

Authors:  Hadeel Majeed; Osnat Gillor; Benjamin Kerr; Margaret A Riley
Journal:  ISME J       Date:  2010-07-22       Impact factor: 10.302

Review 4.  A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression.

Authors:  Erin M Nawrocki; Hillary M Mosso; Edward G Dudley
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

5.  Sublethal concentrations of ciprofloxacin induce bacteriocin synthesis in Escherichia coli.

Authors:  Borut Jerman; Matej Butala; Darja Zgur-Bertok
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

6.  Evolution of microcin V and colicin Ia plasmids in Escherichia coli.

Authors:  Anne Jeziorowski; David M Gordon
Journal:  J Bacteriol       Date:  2007-07-20       Impact factor: 3.490

7.  CdiA from Enterobacter cloacae delivers a toxic ribosomal RNase into target bacteria.

Authors:  Christina M Beck; Robert P Morse; David A Cunningham; Angelina Iniguez; David A Low; Celia W Goulding; Christopher S Hayes
Journal:  Structure       Date:  2014-03-20       Impact factor: 5.006

8.  Green fluorescent protein-based biosensor to detect and quantify stress responses induced by DNA-degrading colicins.

Authors:  Sam Abraham; James Chin; Huub J M Brouwers; Bernadette Turner; Ren Zhang; Toni A Chapman
Journal:  Appl Environ Microbiol       Date:  2011-07-29       Impact factor: 4.792

Review 9.  Pathogen Colonization Resistance in the Gut and Its Manipulation for Improved Health.

Authors:  Joseph M Pickard; Gabriel Núñez
Journal:  Am J Pathol       Date:  2019-05-14       Impact factor: 4.307

Review 10.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.